Many patients with serious diseases are not helped by their medications because treatment is started too late. An international research team led from Linköping University is launching a unique strategy for discovering a disease progression in its earliest phase.
The study, to be published in Science Translational Medicine, has been led by Professor Mikael Benson and Dr Mika Gustafsson at the Centre for Individualized Medication (CIMed).
"We're addressing one of the biggest problems in healthcare, one that leads to a great deal of suffering and enormous costs in terms of drugs and drug development. An important reason for this is that treatment is often not started until the patient has enough symptoms for a diagnosis using conventional methods," says Prof Benson.